AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs

Go back to AtaiBeckley’s BPL-003 Shows Rapid, Durable Antidepressant Response in Treatment-Resistant Depression Patients on SSRIs; Phase 2a Data Published in CNS Drugs
ATA, Inc. (NASDAQ: ATAI) Delayed: 4.09 +0.04 (0.99%)
Previous Close $4.05    52 Week High $7.32 
Open $3.99    52 Week Low $3.30 
Day High $4.11    P/E N/A 
Day Low $3.96    EPS $0.00 
Volume 611,751